POMDOCTOR LTD Financials
This page shows POMDOCTOR LTD (POM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
Thin unit economics force persistent cash burn, so the business currently runs on outside funding rather than self-financing.
Financing cash flow of$22.0M nearly covered operating cash burn of-$21.2M , so the company’s liquidity was effectively replenished by external capital rather than by converting sales into cash. Because capital spending was only$144K , the-$21.4M free-cash-flow deficit came from the operating model itself, not from a business requiring heavy physical reinvestment.
A gross margin of
The balance-sheet posture is creditor-funded: total liabilities of
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of POMDOCTOR LTD's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
POMDOCTOR LTD has an operating margin of -29.7%, meaning the company retains $-30 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses.
POMDOCTOR LTD's current ratio of 0.48 is below the typical benchmark, resulting in a score of 4/100. This tight liquidity could limit financial flexibility if cash inflows slow.
While POMDOCTOR LTD generated -$21.2M in operating cash flow, capex of $144K consumed most of it, leaving -$21.4M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
For every $1 of reported earnings, POMDOCTOR LTD generates $1.13 in operating cash flow (-$21.2M OCF vs -$18.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
POMDOCTOR LTD earns $-30.1 in operating income for every $1 of interest expense (-$17.0M vs $563K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
POMDOCTOR LTD generated $57.2M in revenue in fiscal year 2025.
POMDOCTOR LTD's EBITDA was -$16.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
POMDOCTOR LTD reported -$18.7M in net income in fiscal year 2025.
Cash & Balance Sheet
POMDOCTOR LTD generated -$21.4M in free cash flow in fiscal year 2025, representing cash available after capex.
POMDOCTOR LTD held $1.4M in cash against $11.7M in long-term debt as of fiscal year 2025.
POMDOCTOR LTD had 21M shares outstanding in fiscal year 2025.
Margins & Returns
POMDOCTOR LTD's gross margin was 13.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.
POMDOCTOR LTD's operating margin was -29.7% in fiscal year 2025, reflecting core business profitability.
POMDOCTOR LTD's net profit margin was -32.7% in fiscal year 2025, showing the share of revenue converted to profit.
Capital Allocation
POMDOCTOR LTD invested $1.8M in research and development in fiscal year 2025.
POMDOCTOR LTD invested $144K in capex in fiscal year 2025, funding long-term assets and infrastructure.
POM Income Statement
| Metric | Q4'25 |
|---|---|
| Revenue | N/A |
| Cost of Revenue | N/A |
| Gross Profit | N/A |
| R&D Expenses | N/A |
| SG&A Expenses | N/A |
| Operating Income | N/A |
| Interest Expense | N/A |
| Income Tax | N/A |
| Net Income | N/A |
| EPS (Diluted) | N/A |
POM Balance Sheet
| Metric | Q4'25 |
|---|---|
| Total Assets | $15.4M |
| Current Assets | $15.0M |
| Cash & Equivalents | $1.4M |
| Inventory | $1.2M |
| Accounts Receivable | $2.6M |
| Goodwill | N/A |
| Total Liabilities | $80.3M |
| Current Liabilities | $31.2M |
| Long-Term Debt | $11.7M |
| Total Equity | -$64.9M |
| Retained Earnings | -$354.1M |
POM Cash Flow Statement
| Metric | Q4'25 |
|---|---|
| Operating Cash Flow | N/A |
| Capital Expenditures | N/A |
| Free Cash Flow | N/A |
| Investing Cash Flow | N/A |
| Financing Cash Flow | N/A |
| Dividends Paid | N/A |
| Share Buybacks | N/A |
POM Financial Ratios
| Metric | Q4'25 |
|---|---|
| Gross Margin | N/A |
| Operating Margin | N/A |
| Net Margin | N/A |
| Return on Equity | N/A |
| Return on Assets | N/A |
| Current Ratio | 0.48 |
| Debt-to-Equity | -0.18 |
| FCF Margin | N/A |
Note: Shareholder equity is negative (-$64.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.48), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
What is POMDOCTOR LTD's annual revenue?
POMDOCTOR LTD (POM) reported $57.2M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is POMDOCTOR LTD profitable?
No, POMDOCTOR LTD (POM) reported a net income of -$18.7M in fiscal year 2025, with a net profit margin of -32.7%.
What is POMDOCTOR LTD's EBITDA?
POMDOCTOR LTD (POM) had EBITDA of -$16.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does POMDOCTOR LTD have?
As of fiscal year 2025, POMDOCTOR LTD (POM) had $1.4M in cash and equivalents against $11.7M in long-term debt.
What is POMDOCTOR LTD's gross margin?
POMDOCTOR LTD (POM) had a gross margin of 13.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is POMDOCTOR LTD's operating margin?
POMDOCTOR LTD (POM) had an operating margin of -29.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is POMDOCTOR LTD's net profit margin?
POMDOCTOR LTD (POM) had a net profit margin of -32.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is POMDOCTOR LTD's free cash flow?
POMDOCTOR LTD (POM) generated -$21.4M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is POMDOCTOR LTD's operating cash flow?
POMDOCTOR LTD (POM) generated -$21.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are POMDOCTOR LTD's total assets?
POMDOCTOR LTD (POM) had $15.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are POMDOCTOR LTD's capital expenditures?
POMDOCTOR LTD (POM) invested $144K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does POMDOCTOR LTD spend on research and development?
POMDOCTOR LTD (POM) invested $1.8M in research and development during fiscal year 2025.
What is POMDOCTOR LTD's current ratio?
POMDOCTOR LTD (POM) had a current ratio of 0.48 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is POMDOCTOR LTD's debt-to-equity ratio?
POMDOCTOR LTD (POM) had a debt-to-equity ratio of -0.18 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is POMDOCTOR LTD's return on assets (ROA)?
POMDOCTOR LTD (POM) had a return on assets of -121.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is POMDOCTOR LTD's cash runway?
Based on fiscal year 2025 data, POMDOCTOR LTD (POM) had $1.4M in cash against an annual operating cash burn of $21.2M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is POMDOCTOR LTD's debt-to-equity ratio negative or unusual?
POMDOCTOR LTD (POM) has negative shareholder equity of -$64.9M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Are POMDOCTOR LTD's earnings high quality?
POMDOCTOR LTD (POM) has an earnings quality ratio of 1.13x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can POMDOCTOR LTD cover its interest payments?
POMDOCTOR LTD (POM) has an interest coverage ratio of -30.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is POMDOCTOR LTD?
POMDOCTOR LTD (POM) scores 1 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.